Asklepios Klinik Barmbek

Hamburg 22307

1 studies enrolling now · 9 studies all time

What they study most

Acute Coronary Syndrome, Arrhythmia, Atrial Fibrillation, Coronary Artery Disease, Hypertension, Intracerebral Hemorrhage, Multiple Sclerosis, Relapsing-Remitting, Myocardial Infarction, Open Midline Laparotomy, Parkinson´s Disease, Percutaneous Coronary Intervention, Secondary Prevention

Studies at this site

• Prophylactic Reinforcement of Ventral Abdominal Incisions Trial — Recruiting now
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• Rostock International Parkinson's Disease Study (ROPAD) — Completed
• Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation — Completed
• Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial — Completed
• Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed
• An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab — Completed
• The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial — Completed
• Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) — Stopped early